1. Home
  2. LZ vs DRTS Comparison

LZ vs DRTS Comparison

Compare LZ & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LegalZoom.com Inc.

LZ

LegalZoom.com Inc.

HOLD

Current Price

$6.09

Market Cap

1.0B

Sector

Technology

ML Signal

HOLD

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$10.57

Market Cap

978.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LZ
DRTS
Founded
2001
2015
Country
United States
Israel
Employees
N/A
121
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
978.2M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
LZ
DRTS
Price
$6.09
$10.57
Analyst Decision
Hold
Strong Buy
Analyst Count
9
3
Target Price
$9.79
$8.67
AVG Volume (30 Days)
3.3M
975.6K
Earning Date
05-06-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$756,043,000.00
N/A
Revenue This Year
$11.50
N/A
Revenue Next Year
$7.08
$699.98
P/E Ratio
$653.00
N/A
Revenue Growth
10.88
N/A
52 Week Low
$5.28
$2.81
52 Week High
$12.40
$11.62

Technical Indicators

Market Signals
Indicator
LZ
DRTS
Relative Strength Index (RSI) 43.89 57.42
Support Level $5.44 $6.59
Resistance Level $6.74 $11.62
Average True Range (ATR) 0.33 1.01
MACD 0.01 -0.12
Stochastic Oscillator 28.19 62.32

Price Performance

Historical Comparison
LZ
DRTS

About LZ LegalZoom.com Inc.

LegalZoom.com Inc is an online provider of services that meet the legal needs of small businesses and consumers in the United States. The company also offers services that include ongoing compliance and tax advice and filings, business licenses, accounting, virtual mailbox and e-signature solutions, trademark filings, and estate plans.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

Share on Social Networks: